Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid-Free Immunosuppression in De Novo Renal Transplant Recipients
NCT00306397Phase 4Completed
- Sponsor
- University Hospital Basel
- Start
- Jan 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in kidney transplant rejection (2 arms), sponsored by University Hospital Basel. Primary endpoints: Plasma creatinine at 6 months and Creatinine clearance (Cockcroft) at 6 months. Started Jan 2005; status: completed.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00306397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306397.